Other Indications Under Study Phase 3 trials are ongoing for retatrutide in obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease, chronic kidney disease in patients with type 2 diabetes, and cardiovascular outcomes
Dihexa Dihexa is a synthetic peptide derivative of angiotensin IV that has been studied for potent nootropic and neuroprotective effects
Injectable GHK-Cu (Secondary for Hair) Injectable GHK-Cu (subcutaneous, typically 1-2 mg daily in community protocols) provides systemic distribution
There are two types: Melanotan I and Melanotan II
This is a retrospective study and not a randomized controlled trial, so there may be confounding factors affecting which patients were given GLP-1 prescriptions rather than other treatments, despite trial controls
Research indicates that while these medications can be effective for weight loss, some users may experience muscle loss alongside fat loss, particularly when protein intake is insufficient